Following a year-long investigation, 24 people have been indicted on charges related to the large scale manufacture and distribution of methamphetamine in central New York. The 24 individuals indicted have been charged with possession or distribution of pseudoephedrine (PSE) with...

Federal CSIII Classification for PSE May Hold High Potential to Reduce Meth Trafficking and Abuse, NASCSA White Paper Concludes Designating pseudoephedrine (PSE) as a Schedule III controlled substance (CS) at the federal level could have a high potential impact on...

The National Association of Boards of Pharmacy® (NABP®) is offering attendees the opportunity to earn up to nine contact hours (0.9 CEUs) of Accreditation Council for Pharmacy Education-accredited continuing pharmacy education (CPE) credit at its 108th Annual Meeting. The meeting...

Agents of the Oklahoma Bureau of Narcotics and Dangerous Drugs Control (OBN), along with local law enforcement officers, have initiated a sting operation targeting customers who purchase or attempt to purchase pseudoephedrine (PSE) products to produce methamphetamine. Beginning November 4,...

Originally published in the October 2011 Washington Board of Pharmacy Newsletter Washington has become one of 18 states to implement the National Precursor Log Exchange (NPLEx) electronic tracking system to stop the production of methamphetamine. The Washington State Board of...

Originally published in the October 2011 North Carolina Board of Pharmacy Newsletter H12 (Session Law 2011-240) requires all “retailers” to submit required information to the National Precursor Log Exchange – or NPLEx (not to be confused with NAPLEX®) – an...

In Tennessee, a new law aimed to combat the illegal manufacture of methamphetamine (meth) was approved by Governor Bill Haslam on June 6, 2011. As explained in a news release on the governor’s Web site, the law will require that...

Originally published in the May 2011 NABP Newsletter On February 23, 2011, Sheriff Joe Guy of McMinn County, TN, released a community memorandum requesting retailers in his jurisdiction to stop selling pseudoephedrine (PSE) products for 100 days – his plea...

Georgia House of Representatives passed a bill that would restrict sales of pseudoephedrine (PSE) products to pharmacies, thus making it illegal for the medication to be sold by any retail establishment without a pharmacy. As reported by Georgia’s WSBTV, the...

A new law in Arkansas will require pharmacists to verify the legitimate medical need of individuals purchasing products containing pseudoephedrine, the key ingredient needed for illegal methamphetamine production. Senate Bill 437 was passed in the legislature and was signed into...

All pharmacies and retailers in the state of South Carolina that sell over-the-counter cold and allergy medications containing ephedrine, pseudoephedrine, and/or phenylpropanolamine products (PSE) are required to participate in a statewide, real-time electronic PSE monitoring program for the purpose of...

Effective November 1, 2010, the Oklahoma State Board of Pharmacy has implemented a regulation stating that any person with a previous meth-related drug offense may not possess pseudoephedrine (PSE) at all. If a pharmacy sells PSE over the counter, then...

Signed into law by President Obama on October 12, 2010, the Combat Methamphetamine Enhancement Act of 2010 (HR 2923) amends the Controlled Substances Act to effectively require all regulated retail sellers of drug products containing methamphetamine precursors to submit to...

Due to its failure to ensure compliance with pseudoephedrine (PSE) product sales limits, CVS Pharmacy, Inc, in an agreement with federal prosecutors, will pay $77.6 million in penalties and forfeiture. CVS admitted that, from September 2007 to November 2008, the...

Pharmacies in Missouri are beginning to implement a database that will track sales of pseudoephedrine (PSE), the primary precursor ingredient in the illegal manufacture of methamphetamine, and automatically deny sales to customers who have already purchased the legal daily limit....

Published in the September 2010 Kansas State Board of Pharmacy Newsletter For Kansas methamphetamine cooks, getting a key ingredient for making the illegal drug is about to get much more difficult. The Kansas State Board of Pharmacy adopted the Kansas...

The process of implementing a new electronic system to track the sales of pseudoephedrine (PSE), ephedrine, and phenylpropanolamine will begin in Washington State this month. New legislation (PDF) requiring the electronic PSE tracking system was adopted in March 2010. Once...

Iowa pharmacies will soon be linked to a real-time pseudoephedrine (PSE) sales tracking system designed to enable pharmacies across the state to share PSE sales data, as reported in the WCF Courier. By linking the PSE data from all pharmacies,...

Four pharmacies in Terre Haute, IN, have adopted policies requiring that patients present prescriptions in order to purchase products containing pseudoephedrine (PSE) or ephedrine. The result of a summit involving police agencies and business owners, local Kmart, Wal-Mart, JR Pharmacy,...

Reprinted from the October 2009 Minnesota Board of Pharmacy Newsletter. A large number of bills related to the profession of pharmacy or to pharmaceutical manufacturers were introduced this past session. Descriptions of some of the provisions that were enacted into...

Published in the June 2008 Kentucky Board of Pharmacy Newsletter The passage of SB 88 in 2007 allowed the Commonwealth of Kentucky to link all pharmacies in the Commonwealth to one centrally located database. By linking together into one database,...

Published in the March 2008 New Mexico Board of Pharmacy Newsletter The New Mexico Board of Pharmacy designated Albuquerque Police Department Detective Brian Sallee as an agent of the Board. Detective Sallee is authorized to collect and copy information from...

Published in the January 2007 Oklahoma State Board of Pharmacy Newsletter Controlled Dangerous Substances (CDS) Identification (ID) Requirements: As of February 1, 2007, the Oklahoma Bureau of Narcotics & Dangerous Drugs (OBNDD) will be checking for customer IDs on control...

Published in the November 2006 Missouri Board of Pharmacy Newsletter Effective August 28, 2006, legend pseudoephedrine-containing products are no longer controlled substances (CS) in Missouri. The annual inventory of these products is no longer required. Nurse practitioners and physician assistants...

Published in the October 2006 Oklahoma State Board of Pharmacy Newsletter Pseudoephedrine (PSE) Training: As of September 30, 2006, retailers must train their employees on the new PSE restrictions using Drug Enforcement Administration (DEA) materials. Go to www.deadiversion.usdoj.gov/meth/trg_retail_081106.pdf. Reporting PSE...

Published in the August 2006 Alabama State Board of Pharmacy Newsletter On March 9, 2006, President George W. Bush signed legislation enacting the USA PATRIOT Act, Title VII of which is the Combat Methamphetamine Act of 2005. This federal law...

Published in the July 2006 South Dakota State Board of Pharmacy Newsletter As you know, the South Dakota Legislature passed legislation that went into effect July 1, 2006. The South Dakota law prohibits the sale or purchase of more than...

Reprinted from the July 2006 Minnesota Board of Pharmacy Newsletter. The federal Combat Methamphetamine Epidemic Act of 2005 was signed into law on March 9, 2006. Parts of this law are at odds with a state law enacted by the...

Reprinted from the July 2006 Nevada State Board of Pharmacy Newsletter. As part of the renewal of the USA Patriot Act, the federal government enacted nationwide restrictions on the sale of pseudoephedrine, ephedrine, and phenylpropanolamine designed to curtail the production...

Published in the July 2006 Washington State Board of Pharmacy Newsletter On March 6, 2006, the USA Patriot Act reauthorization bill was enacted. This bill included new federal requirements intended to combat the production and distribution of methamphetamine. The Board...

Published in the July 2006 Oklahoma State Board of Pharmacy Newsletter Pharmacists: Please remember that when changing the pharmacy manager, a controlled drug inventory must be taken and sent to the Board within ten (10) days. Also, please include the...

Published in the June 2006 Idaho Board of Pharmacy Newsletter House Bill No. 530 addressed the sale of pseudoephedrine. 37-3301. DEFINITIONS. As used in this chapter: 1. “Pseudoephedrine product” means any compound, mixture or preparation containing any detectable quantity of...

Published in the May 2006 Missouri Board of Pharmacy Newsletter Congress recently passed, and President George W. Bush signed into law, the new Patriot Act, which also contains the federal initiative to thwart the manufacturing and distribution of methamphetamine. There...

Published in the April 2006 Washington State Board of Pharmacy Newsletter There was a change to the rules described in the January 2006 Newsletter that restrict the sale of products containing ephedrine, pseudoephedrine, and phenylpropanolamine. Following a meeting with the...

Published in the April 2006 South Dakota State Board of Pharmacy Newsletter Following is the revised pseudoephedrine bill which will go into effect July 1, 2006. ENTITLED, An Act to revise certain provisions pertaining to the sale, purchasing, and possession...

Reprinted from the April 2006 Minnesota Board of Pharmacy Newsletter. In 2005, Minnesota joined the ranks of states that have placed additional restrictions on the methamphetamine precursor drugs ephedrine and pseudoephedrine. Most products containing these drugs, either alone or in...

Published in the February 2006 Missouri Board of Pharmacy Newsletter As most readers already know, a law dealing with added controls on ephedrine and pseudoephedrine products went into effect in June 2005. Pure ephedrine and pseudoephedrine were classified under state...

Published in the January 2006 South Dakota State Board of Pharmacy Newsletter During the 2005 Legislative Session, a bill was introduced to restrict the sale of non-prescription products containing pseudoephedrine or ephedrine. The Legislature passed this bill and enacted statute...

Published in the January 2006 Washington State Board of Pharmacy Newsletter On May 11, 2005, the legislature passed Engrossed Subsitute House Bill 2266. This bill requires the Washington State Board of Pharmacy to enact rules to restrict access to products...